Niyati Goradia

Niyati Goradia

Auto-generated profile, based on publicly available information

Niyati Goradia

Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Cancer Cell
Verified
Journal Article
Closed access
ATAstha Thakkar
Astha Thakkar
JGJesus D. Gonzalez-Lugo
Jesus D. Gonzalez-Lugo
NGNiyati Goradia
Niyati Goradia
RGRadhika Gali
Radhika Gali
LSLauren C. Shapiro
Lauren C. Shapiro
Balazs HalmosBalazs Halmos
Balazs Halmos

1 April 2021 in Clinical Lymphoma Myeloma and Leukemia
Verified
Journal Article
Closed access
GKGurbakhash Kaur
Gurbakhash Kaur
MSMateo Mejia Saldarriaga
Mateo Mejia Saldarriaga
NSNishi Shah
Nishi Shah
DCDonna D. Catamero
Donna D. Catamero
LYLihua Yue
Lihua Yue
MJMurali Janakiram
Murali Janakiram

29 November 2022 in Acta Haematologica
Verified
Journal Article
Open access
NGNiyati Goradia
Niyati Goradia
ASAditi Shastri
Aditi Shastri
AVAmit Verma
Amit Verma
EFEric Feldman
Eric Feldman
DCDennis L Cooper
Dennis L Cooper
MGMendel Goldfinger
Mendel Goldfinger
Introduction: Myeloid malignancies are a heterogeneous group of clonal bone marrow disorders that are complex to manage in the community and therefore often referred to subspecialists at tertiary oncology referral centers. Many patients do not live in close proximity to tertiary referral centers and are unable to commute long distances due to age, comorbidities, and frailty. Interventions that minimize the travel time burden without compromising quality of care are an area of unmet need. We describe a cancer care delivery model for patients with myeloid malignancies that is built around telehealth and enables this vulnerable population access to care at an NCI-designated cancer center while receiving majority of their care close to home. Methods and Materials: We report on a cohort of patients with myeloid malignancies who were co-managed by a general community oncologist and an academic leukemia subspecialist at Montefiore Einstein Cancer Center in New York. Patients were initially referred to our institute for a second opinion by community practices that are in partnership with Montefiore Health System, and initial visits were in-person or via telehealth. Treatment plans were made after discussion with patient’s local community oncologist. Patients then continued to receive majority of their treatment and supportive care including transfusion support with their local oncologist, and follow-up visits were mainly via telehealth with the academic leukemia subspecialist. Results: Our cohort of 12 patients had a median age of 81 years (range, 59–88 years). Patients remained on active treatment for a median time of 357 days (range, 154–557 days). Most of our patients had a performance status of ECOG 2 or higher. Three patients had myelodysplastic syndromes, 7 patients had acute myeloid leukemia, and 2 patients had myelofibrosis. The median number of hospitalizations over the total treatment time period was one. Conclusion: We demonstrate a shared academic and community care co-management model for the treatment of myeloid malignancies in elderly, frail patients using telehealth as a backbone with a very low hospitalization rate.